These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4264609)

  • 41. [Indications for the use of tiapride in extrapyramidal pathology].
    Petit H
    Lille Med; 1979 Apr; 24(4):339-44. PubMed ID: 39203
    [No Abstract]   [Full Text] [Related]  

  • 42. Postthalamic stroke dystonic choreoathetosis responsive to tetrabenazine.
    Calabrò RS; Polimeni G; Gervasi G; Bramanti P
    Ann Pharmacother; 2011 Dec; 45(12):e65. PubMed ID: 22116988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Spontaneous oral dyskinesia. Successful treatment with tetrabenazine (author's transl)].
    Schumm F; Dichgans J; Zeller E
    Arch Psychiatr Nervenkr (1970); 1981; 230(4):315-23. PubMed ID: 7316728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.
    Frank S; Ondo W; Fahn S; Hunter C; Oakes D; Plumb S; Marshall F; Shoulson I; Eberly S; Walker F; Factor S; Hunt V; Shinaman A; Jankovic J
    Clin Neuropharmacol; 2008; 31(3):127-33. PubMed ID: 18520979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Physician perceptions of pharmacologic treatment options for chorea associated with Huntington disease in the United States.
    Sung VW; Iyer RG; Gandhi SK; Shah-Manek B; DiBonaventura M; Abler V; Claassen DO
    Curr Med Res Opin; 2018 Apr; 34(4):643-648. PubMed ID: 29383957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tetrabenazine in the treatment of Huntington's chorea and other hyperkinetic movement disorders.
    Toglia JU; McGlamery M; Sambandham RR
    J Clin Psychiatry; 1978 Jan; 39(1):81-7. PubMed ID: 147268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The long-term effect of tetrabenazine in the management of Huntington disease.
    Fasano A; Cadeddu F; Guidubaldi A; Piano C; Soleti F; Zinzi P; Bentivoglio AR
    Clin Neuropharmacol; 2008; 31(6):313-8. PubMed ID: 19050408
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Experiences with memantine in the treatment of severe spastic and extrapyramidal movement disorders in combination with stereotaxic surgery].
    Mundinger F; Milios E
    Nervenarzt; 1985 Feb; 56(2):106-9. PubMed ID: 3885059
    [No Abstract]   [Full Text] [Related]  

  • 49. The treatment of the choreas and athetotic dystonias.
    Godwin-Austen RB
    J R Coll Physicians Lond; 1979 Jan; 13(1):35-8. PubMed ID: 368331
    [No Abstract]   [Full Text] [Related]  

  • 50. The pharmacology of extrapyramidal movement disorders.
    Klawans HL
    Monogr Neural Sci; 1973; 2():1-136. PubMed ID: 4271860
    [No Abstract]   [Full Text] [Related]  

  • 51. Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both.
    Pakkenberg H; Fog R
    Arch Neurol; 1974 Nov; 31(5):352-3. PubMed ID: 4607088
    [No Abstract]   [Full Text] [Related]  

  • 52. Tetrabenazine: for chorea associated with Huntington's disease.
    Scott LJ
    CNS Drugs; 2011 Dec; 25(12):1073-85. PubMed ID: 22133328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease.
    Heo YA; Scott LJ
    Drugs; 2017 Nov; 77(17):1857-1864. PubMed ID: 29080203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short-term effects of tetrabenazine on chorea associated with Huntington's disease.
    Kenney C; Hunter C; Davidson A; Jankovic J
    Mov Disord; 2007 Jan; 22(1):10-3. PubMed ID: 17078062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Tetrabenazine (tetrabenazine Orphan) orally].
    J Pharm Belg; 2014 Dec; (4):49-50. PubMed ID: 25562927
    [No Abstract]   [Full Text] [Related]  

  • 56. [Editorial: Treatment of choriatic movements].
    Nyberg-Hansen R
    Tidsskr Nor Laegeforen; 1975 Nov; 95(33):1928-30. PubMed ID: 127403
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of tetrabenazine in some hyperkinetic syndromes.
    Pakkenberg H
    Acta Neurol Scand; 1968; 44(3):391-3. PubMed ID: 4235247
    [No Abstract]   [Full Text] [Related]  

  • 58. Long-term effects of tetrabenazine in hyperkinetic movement disorders.
    Jankovic J; Beach J
    Neurology; 1997 Feb; 48(2):358-62. PubMed ID: 9040721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tetrabenazine Treatment Patterns and Outcomes for Chorea Associated with Huntington Disease: A Retrospective Chart Review.
    Claassen DO; Iyer RG; Shah-Manek B; DiBonaventura M; Abler V; Sung VW
    J Huntingtons Dis; 2018; 7(4):345-353. PubMed ID: 30282372
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deutetrabenazine for the treatment of Huntington's chorea.
    Bashir H; Jankovic J
    Expert Rev Neurother; 2018 Aug; 18(8):625-631. PubMed ID: 29996061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.